| Income Statement | 2026-03-31 | 2025-03-31 | ||
|---|---|---|---|---|
| Revenues, net | 1,034,385 | 817,898 | ||
| Cost of revenues | 332,262 | 389,381 | ||
| Gross profit | 702,123 | 428,517 | ||
| Selling and marketing expenses | 160,731 | 158,136 | ||
| General and administrative expenses | 1,376,793 | 1,060,340 | ||
| Total operating expenses | 1,537,524 | 1,218,476 | ||
| Loss from operations | -835,401 | -789,959 | ||
| Other income, net | - | 69,471 | ||
| Interest income | 163 | 79 | ||
| Other income | 14,252 | - | ||
| Total other income | 14,415 | 69,550 | ||
| Loss before income tax | -820,986 | -720,409 | ||
| Income tax expense | 16,660 | - | ||
| Net loss | -837,646 | -720,409 | ||
| Foreign currency translation adjustment | 7,690 | 3,562 | ||
| Total comprehensive loss | -829,956 | -716,847 | ||
| Basic EPS | -0.027 | -0.024 | ||
| Diluted EPS | -0.027 | -0.024 | ||
| Basic Average Shares | 31,484,324 | 29,995,000 | ||
| Diluted Average Shares | 31,484,324 | 29,995,000 | ||
Antiaging Quantum Living Inc. (AAQL)
Antiaging Quantum Living Inc. (AAQL)